Axonics® reports second quarter 2022 financial results

Irvine, calif.--(business wire)--axonics, inc. (nasdaq: axnx), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today reported financial results for the three months ended june 30, 2022. “this quarter's record revenue result reflects the growing demand for our best-in-class incontinence solutions,” said raymond w. cohen, chief executive officer of axonics. “sacral neuromodulation revenue grew 39% year o
AXNX Ratings Summary
AXNX Quant Ranking